Kaempferol promotes BMSC osteogenic differentiation and improves osteoporosis by downregulating miR-10a-3p and upregulating CXCL12
Hao Liu, Xin Yi, ShuTing Tu, Chong Cheng, Jun Luo
Journal:MOLECULAR AND CELLULAR ENDOCRINOLOGY
IF:3.87
DOI:10.1016/j.mce.2020.111074
PMID:33157164
Published:2020-11-03
research field:分子生物学药理学干细胞研究骨科
Abstract
Background Kaempferol has improved the functions of various human diseases . Here, we aimed to probe into the potential molecular mechanism of Kaempferol to ameliorate osteoporosis . Methods Micro-computed tomography scanning was applied to assess the bone density of osteoporosis rats induced by ovariectomized. Quantitative real-time PCR was applied to detect the expressions of RUNX2 , Osterix, CXCL12, and miR-10a-3p. Western blot , Alizarin red staining, Alkaline Phosphatase Diethanolamine Activity Kit were applied to confirm the in vitro functions of Kaempferol. RNA Immunoprecipitation and dual-luciferase reporter gene experiments were applied to study the potential mechanism. Results The treatment of Kaempferol raised bone density in osteoporosis rats induced by ovariectomized, and boosted the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), and raised the expressions of RUNX2, Osterix, and CXCL12, and lessened miR-10a-3p. From the potential mechanism analysis, we corroborated that miR-10a-3p and CXCL12 bound to each other, and Kaempferol boosted BMSC osteogenic differentiation and ameliorated osteoporosis by lessening miR-10a-3p and raising CXCL12. Conclusion Our data expounded that Kaempferol boosted BMSC osteogenic differentiation and ameliorated osteoporosis by lessening miR-10a-3p and raising CXCL12.
本文使用的Yeasen产品


